Literature DB >> 17880983

European guidelines on cardiovascular disease prevention in clinical practice: executive summary.

Ian Graham1, Dan Atar, Knut Borch-Johnsen, Gudrun Boysen, Gunilla Burell, Renata Cifkova, Jean Dallongeville, Guy De Backer, Shah Ebrahim, Bjørn Gjelsvik, Christoph Herrmann-Lingen, Arno Hoes, Steve Humphries, Mike Knapton, Joep Perk, Silvia G Priori, Kalevi Pyorala, Zeljko Reiner, Luis Ruilope, Susana Sans-Menendez, Wilma Scholte Op Reimer, Peter Weissberg, David Wood, John Yarnell, José Luis Zamorano.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17880983     DOI： 10.1016/j.atherosclerosis.2007.08.024

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  53 in total

1.  Common clinical practice versus new PRIM score in predicting coronary heart disease risk.

Authors:  Ruth Frikke-Schmidt; Anne Tybjærg-Hansen; Peter Schnohr; Gorm B Jensen; Børge G Nordestgaard
Journal:  Atherosclerosis       Date:  2010-07-27       Impact factor: 5.162

2.  Low-density lipoprotein cholesterol reduction and prevention of cardiovascular disease.

Authors:  Evan A Stein
Journal:  Mayo Clin Proc       Date:  2009-04       Impact factor: 7.616

3.  Five-year follow-up of drug utilization for secondary prevention in coronary artery disease.

Authors:  Sule Apikoglu Rabus; Fikret V Izzettin; Mesut Sancar; Osman Karakaya; Ramazan Kargin; Cevat Yakut
Journal:  Pharm World Sci       Date:  2008-06-19

Review 4.  Can cognitive behaviour therapy be beneficial for heart failure patients?

Authors:  Johan Lundgren; Gerhard Andersson; Peter Johansson
Journal:  Curr Heart Fail Rep       Date:  2015-04

5.  Targeting the IKKβ/mTOR/VEGF signaling pathway as a potential therapeutic strategy for obesity-related breast cancer.

Authors:  Chun-Te Chen; Yi Du; Hirohito Yamaguchi; Jung-Mao Hsu; Hsu-Ping Kuo; Gabriel N Hortobagyi; Mien-Chie Hung
Journal:  Mol Cancer Ther       Date:  2012-07-23       Impact factor: 6.261

Review 6.  Biomarkers and sustainable innovation in cardiovascular drug development: lessons from near and far afield.

Authors:  Russell M Medford; T Forcht Dagi; Robert S Rosenson; Margaret K Offermann
Journal:  Curr Atheroscler Rep       Date:  2013-05       Impact factor: 5.113

7.  Adherence to preventive statin therapy according to socioeconomic position.

Authors:  Helle Wallach-Kildemoes; Morten Andersen; Finn Diderichsen; Theis Lange
Journal:  Eur J Clin Pharmacol       Date:  2013-04-16       Impact factor: 2.953

Review 8.  Hyperlipidaemia in paediatric patients: the role of lipid-lowering therapy in clinical practice.

Authors:  Anthony S Wierzbicki; Adie Viljoen
Journal:  Drug Saf       Date:  2010-02-01       Impact factor: 5.606

Review 9.  The role of aspirin in the prevention of cardiovascular disease.

Authors:  Sunitha V Ittaman; Jeffrey J VanWormer; Shereif H Rezkalla
Journal:  Clin Med Res       Date:  2014-02-26

10.  Current European guidelines for management of arterial hypertension: are they adequate for use in primary care? Modelling study based on the Norwegian HUNT 2 population.

Authors:  Halfdan Petursson; Linn Getz; Johann A Sigurdsson; Irene Hetlevik
Journal:  BMC Fam Pract       Date:  2009-10-30       Impact factor: 2.497
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.